NorthRock Partners, LLC
- SEC CIK
- 0001632097
- Latest filing
- Aug 11, 2026
MRNA holding history
Moderna, Inc. in every 13F filed by NorthRock Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRNA overviewAll 13F holders of MRNAFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −3,195−100.0% | Sold out | Holders |
| Q3 2024 | 3,195 | $213.5K | <0.1% | −1,148−26.4% | Reduced | Holders |
| Q2 2024 | 4,343 | $515.7K | <0.1% | +418+10.6% | Added | Holders |
| Q1 2024 | 3,925 | $418.2K | <0.1% | +638+19.4% | Added | Holders |
| Q4 2023 | 3,287 | $326.9K | <0.1% | +3,287 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −1,681−100.0% | Sold out | Holders |
| Q1 2023 | 1,681 | $258.2K | <0.1% | −394−19.0% | Reduced | Holders |
| Q4 2022 | 2,075 | $372.7K | <0.1% | +2,075 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −1,820−100.0% | Sold out | Holders |
| Q2 2022 | 1,820 | $260.0K | <0.1% | +254+16.2% | Added | Holders |
| Q1 2022 | 1,566 | $270.0K | <0.1% | +193+14.1% | Added | Holders |
| Q4 2021 | 1,373 | $349.0K | <0.1% | +455+49.6% | Added | Holders |
| Q3 2021 | 918 | $396.0K | <0.1% | +918 | New | Holders |